Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL105586-04
|
|
Optimization of Hyperpolarized Xenon-129 Diffusion MRI for COPD
|
MILLER, G.
|
UNIVERSITY OF VIRGINIA
|
VA
|
$373,143
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL112707-03
|
|
Sarcoidosis and A1AT Genomics & Informatics Center
|
WISNIEWSKI, STEPHEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$2,447,769
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
7F32ES023352-02
|
|
Air pollution exposure and COPD in the Framingham Heart Study
|
RICE, MARY
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$58,022
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL111527-04
|
|
Non-coding RNA structure change in Chronic Obstructive Pulmonary Disease
|
LAEDERACH, ALAIN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$354,651
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
5R01ES016285-05
|
|
RTP-801 in Cigarette Smoke-Emphysema
|
TUDER, RUBIN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$303,103
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K23HL096467-05
|
|
HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease
|
GEORGE, MARJORIE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$131,139
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL110942-04
|
|
Epigenic Regulation of Lung Progenitor Repair and Regeneration
|
MORRISEY, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$663,857
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R21HL121744-02
|
|
Health Literacy-Sensitive Decision Aid about Transplantation for COPD Patients
|
PILEWSKI, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$189,513
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL085613-07
|
|
MECHANISMS OF CIGARETTE SMOKE-INDUCED LUNG CELLULAR SENESCENCE
|
RAHMAN, IRFAN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$377,993
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL116514-02
|
|
MMP28 Regulation Of Macrophage Recruitment and Polarization
|
MANICONE, ANNE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$428,475
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL118268-02
|
|
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
|
KNOELL, DAREN
|
OHIO STATE UNIVERSITY
|
OH
|
$279,981
|
Chronic Obstructive Pulmonary Disease
|
2015
|
OD
|
5R01HL118268-02
|
|
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
|
KNOELL, DAREN
|
OHIO STATE UNIVERSITY
|
OH
|
$100,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K24HL087713-07
|
|
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$181,443
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL112987-03
|
|
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema
|
INGENITO, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$816,611
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL112986-03
|
|
Multi-center Structural & Functional Quantitative CT Pulmonary Phenotyping
|
HOFFMAN, ERIC
|
UNIVERSITY OF IOWA
|
IA
|
$1,128,991
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL116931-03
|
|
Airway Inspector: a chest imaging biomarker software platform for COPD
|
SAN JOSE ESTEPAR, RAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$436,170
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL105487-05
|
|
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$446,920
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL116473-03
|
|
The clinical impact of pulmonary vascular remodeling in smokers
|
WASHKO, GEORGE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$462,911
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL093081-06
|
|
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
|
BARR, R
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$746,619
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL110883-04
|
|
Ancillary T Cell Based Studies in SPIROMICS
|
KHERADMAND, FARRAH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$391,478
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL117637-03
|
|
Paracorporeal Ambulatory Assist Lung
|
FEDERSPIEL, WILLIAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$674,332
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL105772-04
|
|
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema
|
PETRACHE, IRINA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$94,267
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P20HL113445-04
|
|
Metabolic profiles of COPD phenotypes
|
BOWLER, RUSSELL
|
NATIONAL JEWISH HEALTH
|
CO
|
$1,104,879
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R21HL120794-02
|
|
Functional Genomic Approaches to Dissect COPD GWAS Loci
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$222,206
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K99HL125756-01
|
|
Nitric oxide coupling and BH4 availability roles in muscle dysfunction with COPD
|
LAYEC, GWENAEL
|
UNIVERSITY OF UTAH
|
UT
|
$138,780
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R21HL125574-01
|
|
Nutritional Genomics of Pulmonary Function
|
HANCOCK, DANA
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$189,302
|
Chronic Obstructive Pulmonary Disease
|
2015
|
OD
|
1R21HL125574-01
|
|
Nutritional Genomics of Pulmonary Function
|
HANCOCK, DANA
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$46,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K99HL125899-01
|
|
Mitochondrial Iron metabolism in Chronic Obstructive Pulmonary Disease
|
CLOONAN, SUZANNE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$132,381
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL056177-19
|
|
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life
|
MARTINEZ, FERNANDO
|
UNIVERSITY OF ARIZONA
|
AZ
|
$1,102,034
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R21HL126032-01
|
|
Genome-wide gene-by-smoking interaction analysis of pulmonary function
|
MORRISON, ALANNA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$154,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL118857-03
|
|
HIV-related Accelerated Aging of the Airway Epithelium
|
CRYSTAL, RONALD
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$802,906
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL071589-13
|
|
Forkhead Repressors and Lung Development
|
MORRISEY, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$354,389
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
5R01ES023500-02
|
|
SPIROMICS - Air Pollution Study
|
HANSEL, NADIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$649,030
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
5R01ES019853-04
|
|
COPD and Response to Traffic Related Particles
|
GARSHICK, ERIC
|
HARVARD MEDICAL SCHOOL
|
MA
|
$598,142
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL010342-47
|
7525
|
Role of CD8+T cells and macrophages in chronic emphysema
|
MITZNER, WAYNE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$481,163
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R00HL103786-05
|
|
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and Fatigue
|
AMANN, MARKUS
|
UNIVERSITY OF UTAH
|
UT
|
$245,266
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R44HL118837-03
|
|
CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression
|
HATT, CHARLES
|
IMBIO, LLC
|
MN
|
$564,374
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL122464-01A1
|
|
Skeletal muscle, subcutaneous fat, and clinical outcomes in smokers
|
WASHKO, GEORGE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$545,234
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1R01ES023842-01A1
|
|
A Novel mechanism for Environmentally Induced Airway Disease
|
MEZRICH, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$344,250
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5R21CA176256-02
|
|
Role of SIRT1 in Lung Cancer Prevention by Beta-Cryptoxanthin
|
WANG, XIANG-DONG
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$164,213
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R00HL113105-04
|
|
Mechanisms of Teleomere-Mediated Emphysema
|
ALDER, JONATHAN
|
BRIGHAM YOUNG UNIVERSITY
|
UT
|
$245,266
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K99HL121087-01A1
|
|
Network Medicine Approaches to Cachexia in COPD
|
MCDONALD, MERRY-LYNN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$136,350
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL113264-04
|
|
Identifying Genetic Determinants of Severe, Early-Onset COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,007,670
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5R01CA166703-03
|
|
Predicting Pulmonary Function Change to Improve Radiation Planning and Outcome
|
BAYOUTH, JOHN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$371,734
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL119538-02
|
|
Clec5a regulation of Macrophage function in COPD
|
BORCHERS, MICHAEL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$389,382
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K08HL121168-02
|
|
EPITHELIAL IL-33 IN THE PATHOGENESIS OF CHRONIC AIRWAY DISEASE
|
ALEXANDER-BRETT, JENNIFER
|
WASHINGTON UNIVERSITY
|
MO
|
$114,196
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL113032-04
|
|
Role of genetic variation in TGF-beta overactivation in COPD
|
NISHIMURA, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$503,500
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL117104-03
|
|
Cellular and Molecular Mechanisms of bitter tastant-induced bronchodilation
|
ZHUGE, RONGHUA
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$412,468
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL122477-02
|
|
Lung Function Decline and Disease Risk from Young Adulthood to Middle Age
|
KALHAN, RAVI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$710,581
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL111294-04
|
|
Human Lung Regional Ventilation Defect Severity Measured by Fluorine-19 Gas MRI
|
CHARLES, HAL
|
DUKE UNIVERSITY
|
NC
|
$589,549
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL077328-10
|
|
Ceramide-induced lung destruction in emphysema
|
PETRACHE, IRINA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$41,144
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K23HL114735-03
|
|
Using Vessel Caliber to Assess Cardiac Impairment in COPD
|
COME, CAROLYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$163,350
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
5R01ES022607-03
|
|
Clinical trial of air cleaners to improve indoor air quality and COPD health
|
HANSEL, NADIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$673,901
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K01HL118714-03
|
|
Computed Tomographic-Based Assessment of Airway Remodeling in COPD
|
DIAZ, ALEJANDRO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$142,160
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL122438-02
|
|
Parametric Response Mapping in COPD
|
HAN, MEILAN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$903,303
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL111288-04
|
|
Investigating the role of the R213G SOD3 polymorphism in lung disease
|
BOWLER, RUSSELL
|
NATIONAL JEWISH HEALTH
|
CO
|
$280,953
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K24HL123342-02
|
|
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$114,212
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL116597-03
|
|
Role of Lung MSC in Emphysema
|
MAJKA, SUSAN
|
VANDERBILT UNIVERSITY
|
TN
|
$473,673
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL118542-03
|
|
Integrative Omics to Discover Molecular Determinants of COPD
|
LENBURG, MARC
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$673,120
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIAID
|
5K23AI102970-02
|
|
Lung Microbiome and Inflammation in Early COPD
|
SEGAL, LEOPOLDO
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$184,150
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL109618-05
|
|
Simultaneous Xe129 MRI of Regional Lung Ventilation and Gas Uptake in COPD
|
MUGLER, JOHN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$508,145
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL114447-04
|
|
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
|
HUFFNAGLE, GARY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$382,189
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL114494-03
|
|
An integrative statistics-guided image-based multi-scale lung model
|
LIN, CHING-LONG
|
UNIVERSITY OF IOWA
|
IA
|
$627,899
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
5K23ES023700-03
|
|
Endotoxin, the airway transcriptome, and obstructive lung disease
|
LAI, PEGGY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$152,840
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL125169-01A1
|
|
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD
|
NEPTUNE, ENID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$449,417
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL126596-01
|
|
Genetics of Smoke-Altered LTA4H in COPD
|
BLALOCK, J
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$401,792
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL126600-01
|
|
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
|
O'CONNOR, BRIAN
|
NATIONAL JEWISH HEALTH
|
CO
|
$393,891
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL107151-05
|
6979
|
Treating lung inflammation by targeting Siglecs
|
BOCHNER, BRUCE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$317,822
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL107151-05
|
6981
|
Human lung counter-receptors for Siglec-8 and Siglec-9
|
SCHNAAR, RONALD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$366,462
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL107151-05
|
6986
|
Inflammatory Lung Disease Animal Models Core
|
ZHU, ZHOU
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$196,893
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL110950-04
|
|
Acquired LTA4H Dysfunction in COPD
|
BLALOCK, J
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$492,831
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIDCD
|
5R01DC012200-04
|
|
Moraxella catarrhalis: virulence-based prevention
|
MURPHY, TIMOTHY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$410,358
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL103455-05
|
8749
|
Pulmonary hypertension in COPD: genetic and enviormental determinants
|
SHAPIRO, STEPHEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$594,929
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL103455-05
|
8753
|
Pre-clinical animal models of PAH
|
NORRIS, KAREN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$431,570
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL103455-05
|
8754
|
Translational vascular phenomics, genomics, and epidemology
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$465,356
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K23HL111116-03
|
|
Facilitating adoption of COPD evidence-based care in outpatient settings (FACES)
|
FEEMSTER, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$150,752
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K23HL126912-01
|
|
Autoimmunity as a Mechanism for Atherosclerosis in COPD
|
CHANDRA, DIVAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$132,192
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL126838-01
|
|
Defining the role of early pulmonary vascular disease in COPD
|
HOFFMAN, ERIC
|
UNIVERSITY OF IOWA
|
IA
|
$790,711
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL127200-01
|
|
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease
|
ZHOU, ANNY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$442,813
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL108808-04
|
5920
|
Mucus Obstructed Mice for Biomarker and Drug Development
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$480,885
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL108808-04
|
5921
|
Targeting Defective Mucus Clearance in COPD
|
DONALDSON, SCOTT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$454,189
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R34HL127166-01
|
|
A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-TOPIC)
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$296,969
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1R21ES025379-01
|
|
Epigenetic reactivation of human club cell protein 16 in COPD
|
FEDULOV, ALEXEY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$266,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL120398-03
|
|
Translational evaluation of aging, inflammation, and HIV in lung dysfunction
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$678,491
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL117181-03
|
|
Th1 and Th17 Mediators in Experimental Emphysema
|
KHERADMAND, FARRAH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$385,381
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5K07CA187071-02
|
|
Evaluating the Effectiveness of Lung Cancer Screening in Patients with COPD
|
KALE, MINAL
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$169,291
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL086936-07
|
|
Smoke Induced Airway Injury in the Lung
|
D'ARMIENTO, JEANINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$537,809
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL124747-01A1
|
|
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
|
GALBIATI, FERRUCCIO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5R01CA141769-05
|
|
Inflammation Pathways and COPD in the Development of Lung Cancer
|
SCHWARTZ, ANN
|
WAYNE STATE UNIVERSITY
|
MI
|
$1,919,858
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIA
|
1R01AG047891-01A1
|
|
Individualized Absolute Risk calculator For Persons With Multiple Chronic Conditions
|
ALLORE, HEATHER
|
YALE UNIVERSITY
|
CT
|
$307,193
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL114501-03
|
|
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
|
CHOI, AUGUSTINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$2,392,423
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5162
|
Genetics of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$747,135
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5163
|
Genomics of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$473,305
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5164
|
DNA Methylation Marks of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$391,515
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5165
|
Systems Biology, Bioinformatics, and Biostatistics
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$312,896
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5167
|
Integrated Murine Models of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$284,682
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL105339-05
|
5168
|
Administration
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$120,430
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL123544-01A1
|
|
Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
|
SHAYKHIEV, RENAT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$423,750
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
2R01HL077612-09
|
|
Pulmonary microvascular perfusion in the Multi-Ethnic Study of Atherosclerosis
|
BARR, R
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$914,698
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL105546-05
|
|
Pathogenesis and Outcomes of Sleep Disordered Breathing in COPD
|
SCHNEIDER, HARTMUT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$403,850
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL119476-02
|
|
Mechanisms of Telomere-Induced Emphysema
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$584,179
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL121270-02
|
|
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
|
BARR, R
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$433,625
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCCAM
|
5R01AT006358-05
|
|
Tai Chi after Pulmonary Rehabilitation in Patients with COPD: A Randomized Trial
|
YEH, GLORIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$586,312
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL076100-11
|
5037
|
Vaccine strategies against pneumocystis in non-human primates
|
NORRIS, KAREN
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$182,369
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5P01HL076100-11
|
5039
|
Non-human primate core
|
NORRIS, KAREN
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$680,898
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL089856-09
|
|
(2 of 2) Genetic Epidemiology of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$3,199,487
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL121804-03
|
|
MOLECULAR MECHANISMS OF CHRONIC AIRWAY AND ALVEOLAR DISEASE IN HIV
|
ATKINSON, JEFFREY
|
WASHINGTON UNIVERSITY
|
MO
|
$621,875
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL121814-03
|
|
Immune Mechanisms of HIV-associated COPD
|
KIRK, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$698,816
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIAID
|
5R01AI019641-30
|
|
Persistent H. influenzae in COPD - virulence, vaccines and antibiotic resistance
|
MURPHY, TIMOTHY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$772,946
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL121816-03
|
|
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease
|
FONTENOT, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$684,200
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R18HL108810-05
|
|
Implementation and Outcomes of Noninvasive Ventilation in COPD
|
LINDENAUER, PETER
|
BAYSTATE MEDICAL CENTER
|
MA
|
$522,174
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIGMS
|
5P20GM109090-02
|
5348
|
Breathing and Walking Coupling Variability in COPD
|
YENTES, JENNIFER
|
UNIVERSITY OF NEBRASKA OMAHA
|
NE
|
$194,733
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL121827-03
|
|
HIV and COPD:Immune mediated mechanisms
|
MEDOFF, BENJAMIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$655,958
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5U01HL121828-03
|
|
HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
|
CRYSTAL, RONALD
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$744,905
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
2R44HL114162-02A1
|
|
Home-based Health Management of COPD Patients
|
SEIFERT, SARA
|
MINNESOTA HEALTHSOLUTIONS CORPORATION
|
MN
|
$373,357
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R43HL127873-01
|
|
Development of a Fully Humanized Antibody for Treating Lung Emphysema
|
CLAUSS, MATTHIAS
|
EMPHYMAB BIOTECH, LLC
|
IN
|
$227,766
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL111759-04
|
|
Using Networks to Assign Gene Function in Lung Disease
|
QUACKENBUSH, JOHN
|
DANA-FARBER CANCER INST
|
MA
|
$802,927
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5R01CA163293-04
|
|
Pulmonary Rehabiltation before Lung Cancer Resection
|
BENZO, ROBERTO
|
MAYO CLINIC ROCHESTER
|
MN
|
$102,798
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL125432-01A1
|
|
Cathelicidin and Vitamin D: Impact on Populations At-Risk and with COPD
|
DRUMMOND, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$467,913
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1F32HL128026-01
|
|
Hyperinflation and Cardiac Impairment in COPD
|
KOHLI, PUJA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$64,226
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL118541-02
|
|
Integrative-omics Network Model of the Disordered COPD Small Airway Epithelium
|
CRYSTAL, RONALD
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$944,986
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NINR
|
5R01NR013937-03
|
|
Efficacy and mechanisms of a behavioral therapy for insomnia coexisting with COPD
|
KAPELLA, MARY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$492,323
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIA
|
5R44AG039139-03
|
|
A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications
|
LICHTER, PATRICK
|
KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT
|
MN
|
$744,741
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R44HL073591-09
|
|
Clinical Development of a Therapeutic Agent for COPD
|
PARIKH, INDU
|
BIOMARCK PHARMACEUTICALS, LTD
|
NC
|
$1,000,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL120908-02
|
|
Novel therapies for cigarette smoke induced lung injury
|
SIME, PATRICIA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$383,515
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL125049-02
|
|
Longitudinal evaluation of HIV-associated lung disease phenotypes
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$727,478
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL124233-02
|
|
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTL
|
CASTALDI, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$868,847
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL089897-09
|
|
(1 of 2) Genetic Epidemiology of COPD
|
CRAPO, JAMES
|
NATIONAL JEWISH HEALTH
|
CO
|
$7,477,114
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCCAM
|
5R01AT007620-02
|
|
Quercetin prevents progression of COPD lung disease by modulating Foxo3A activity
|
SAJJAN, UMADEVI
|
UNIVERSITY OF MICHIGAN
|
MI
|
$383,670
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5P50CA090440-15
|
5228
|
Targeting Neutrophil Elastase in Lung Cancer
|
SHAPIRO, STEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$342,593
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
5K07CA181480-02
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$127,739
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIA
|
5R21AG048196-02
|
|
Feasibility testing of a decision aid to support shared decision making about inv
|
HAJIZADEH, NEGIN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$204,306
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5K08HL123940-02
|
|
The Role of PGP in COPD-associated Pulmonary Hypertension
|
WELLS, JAMES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$129,330
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NINR
|
5R01NR010006-08
|
|
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement
|
BANZETT, ROBERT
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$421,950
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5F32HL124823-02
|
|
Role of the IL-33/ST2 Axis in the Development of Emphysema
|
CRAIG, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$54,194
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL128156-01
|
|
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$777,563
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL125000-02
|
|
HIV-associated Chronic Obstructive Pulmonary Disease
|
SOPORI, MOHAN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
NM
|
$971,489
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL126536-02
|
|
HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction
|
CROTHERS, KRISTINA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$678,741
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5R01HL118171-02
|
|
DJ-1 pathway impairment in alveolar type II cells in emphysema.
|
KOSMIDER, BEATA
|
NATIONAL JEWISH HEALTH
|
CO
|
$390,306
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
5UH2HL123502-02
|
|
A New Genus of Ubiquitin-Based Anti-inflammatories for COPD
|
MALLAMPALLI, RAMA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$1,477,818
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K08HL128809-01
|
|
A Critical Role for Follistatin-like Protein-1 in Lung Homeostasis
|
CAMPFIELD, BRIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$126,792
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1K23ES025781-01
|
|
Indoor air pollution, mucociliary clearance, and mucus properties in COPD
|
PAULIN, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$166,518
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL129060-01
|
|
CPAP Drives Lung Growth and Pulmonary Function in Moderately Preterm Primates
|
SPINDEL, ELIOT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$812,738
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K01HL129039-01
|
|
Network-based Methods for Understanding Genetic Determinants and Epistasis in COPD
|
QIAO, DANDI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$140,130
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1R21ES025840-01
|
|
Clean Air- Heart: Clinical trial of an air purifier intervention to reduce indoor particulate matter and improve cardiovascular outcomes in COPD
|
MCCORMACK, MEREDITH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$243,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R21HL129112-01
|
|
Xe129 MRI of the Lung: A New Technology to Assess Treatment for COPD
|
QING, KUN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$237,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1U01HL128868-01
|
|
Health through Obesity care for PatiEnts with COPD (HOPE)
|
AU, DAVID
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
WA
|
$314,668
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1U01HL128951-01
|
|
Effect of Losartan on Progression of Emphysema
|
WISE, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$364,500
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1U01HL128952-01
|
|
Redefining Therapy In Early COPD: RETHINC
|
HAN, MEILAN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$363,496
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL129223-01
|
|
HL-p73 is a novel master regulator of the airway epithelium
|
MOLL, UTE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$485,641
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
3R01HL068111-11S1
|
|
Regulation of Mucous Cell Metaplasia in Asthma
|
TESFAIGZI, YOHANNES
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
NM
|
$163,500
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL125816-01A1
|
|
Microbial triggers and molecular mechanisms of Th17 mediated airway inflammation-Resubmission-1
|
KORALOV, SERGEI
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$651,841
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL125583-01A1
|
|
INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE
|
HERSH, CRAIG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$911,563
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K23HL123778-01A1
|
|
Identifying the Th2 endotype in COPD: clinical and pathologic implications
|
CHRISTENSON, STEPHANIE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$139,437
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K23HL123594-01A1
|
|
The association of allergic disease with clinical outcomes in COPD.
|
PUTCHA, NIRUPAMA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$162,943
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K01HL125858-01A1
|
|
Common Genetic Pathways Underlying CVD and COPD
|
LUTZ, SHARON
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$130,830
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1K08HL126071-01A1
|
|
Smoke induced alterations in ion channel function
|
GOLDKLANG, MONICA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$130,842
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL127969-01A1
|
|
Imaging-based characterization of the COPDGene cohort
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$723,493
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL126508-01A1
|
|
Self-management behaviors among COPD patients with multi-morbidity
|
WISNIVESKY, JUAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$808,961
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
2R44HL104902-02A1
|
|
Novel ROCK inhibitors for COPD
|
PFISTER, JURG
|
THERATROPHIX, LLC
|
CA
|
$715,216
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIAID
|
1R01AI120655-01
|
|
Targeting CCL28 as therapy for obstructive lung disease
|
VOLKMAN, BRIAN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$384,791
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIDA
|
1R01DA040395-01
|
|
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles
|
DIAZ, PHILIP
|
OHIO STATE UNIVERSITY
|
OH
|
$513,148
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
2R01HL096453-06A1
|
|
Effects of HIV antiretroviral therapy on pulmonary function in a randomized trial
|
KUNISAKI, KEN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$679,523
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIMHD
|
1P50MD010431-01
|
|
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)
|
HANSEL, NADIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$550,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1P50MD010431-01
|
|
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)
|
HANSEL, NADIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$150,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R21HL129906-01
|
|
Identifying imaging-based biomarkers of COPD development through virtual inhalation experiments
|
COLETTI, FILIPPO
|
UNIVERSITY OF MINNESOTA
|
MN
|
$170,240
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R21HL129924-01
|
|
Albuminuria and incident chronic lung disease exacerbations in five population-based cohorts
|
OELSNER, ELIZABETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$200,000
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL129937-01
|
|
Sphingolipids and inflammatory biomarkers of COPD progression in healthy smokers
|
BOWLER, RUSSELL
|
NATIONAL JEWISH HEALTH
|
CO
|
$395,080
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R01HL129938-01
|
|
Exhaustion of Airway Progenitor Cells Indicates Susceptibility to COPD
|
GHOSH, MOUMITA
|
NATIONAL JEWISH HEALTH
|
CO
|
$409,356
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
268201100024C-4-0-1
|
|
LUNG TISSUE RESEARCH CONSORTIUM (LTRC) DATA COORDINATING CENTER
|
THOMPSON, BRUCE
|
CLINICAL TRIALS AND SURVEYS CORPORATION
|
MD
|
$357,318
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76194-12-0-2
|
|
OPTION IV: 5/1/13 - 12/31/14, LOTT
|
KANNER, RICHARD
|
UNIVERSITY OF UTAH
|
UT
|
$196,442
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76183-14-0-2
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
FUHLBRIGGE, ANNE LOUISE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$190,071
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76196-15-0-1
|
|
Long-term Oxygen Treatment Trial
|
MOTOKI, CONNIE
|
WASHINGTON UNIVERSITY
|
MO
|
$261,439
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76188-12-0-1
|
|
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) - REGIONAL CLINICAL
|
CASABURI, RICHARD
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$165,061
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76186-12-0-2
|
|
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) - REGIONAL CLINICAL CENTER
|
MACINTYRE, NEIL
|
DUKE UNIVERSITY
|
NC
|
$151,777
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76195-10-0-2
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
AU, DAVID
|
UNIVERSITY OF WASHINGTON
|
WA
|
$60,786
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
268201100023C-7-0-1
|
|
LUNG TISSUE RESEARCH CONSORTIUM: TISSUE REPOSITORY
|
SULLIVAN, DIANE
|
NATIONAL JEWISH HEALTH
|
CO
|
$368,072
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76192-13-0-2
|
|
LONG TERM OXYGEN TREATMENT TRAIL (LOTT) - REGIONAL CLINICAL CENTER
|
GAY, STEVEN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$150,320
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76184-11-0-2
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
GAEKE TORRENCE, CHRISTINE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$218,040
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76185-12-0-2
|
|
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) - REGIONAL CLINICAL CENTER
|
ALBERT, RICHARD
|
DENVER HEALTH AND HOSPITAL AUTHORITY
|
CO
|
$46,775
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76187-12-0-1
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
STIBOLT, THOMAS, B.
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$38,750
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76189-14-0-2
|
|
Title: Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
DIAZ, PHILIP T
|
OHIO STATE UNIVERSITY
|
OH
|
$209,214
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76191-12-0-3
|
|
Long Term Oxygen Treatment Trail - Regional Clinical Center
|
COOPER, J. ALLEN D.
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$272,195
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76190-12-0-2
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
CRINER, GERARD
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$291,784
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76193-11-0-2
|
|
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center
|
SCIURBA, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$156,803
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
3R15ES023151-02S1
|
|
NOD-Like Receptor Signaling is Critical to Secondhand Smoke-Induced Immunity and
|
BATRA, SANJAY
|
SOUTHERN UNIV A&M COL BATON ROUGE
|
LA
|
$8,120
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
N01HR76197-12-0-3
|
|
Title: Long-Term Oxygen Treatment Trial (LOTT) - Data Coordinating Center
|
TONASCIA, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$1,168,039
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
3R01HL122438-02S1
|
|
Parametric Response Mapping in COPD
|
HAN, MEILAN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$110,438
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
3R01HL125049-02S1
|
|
Longitudinal evaluation of HIV-associated lung disease phenotypes
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$63,280
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
7R01HL077328-11
|
|
Ceramide-induced Lung Destruction in Emphysema
|
PETRACHE, IRINA
|
NATIONAL JEWISH HEALTH
|
CO
|
$320,023
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
7R01HL105772-05
|
|
Direct and Bone Marrow Mediated Effects of Adipose Stem Cells in Emphysema
|
PETRACHE, IRINA
|
NATIONAL JEWISH HEALTH
|
CO
|
$289,883
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
3R01HL085613-07S1
|
|
MECHANISMS OF CIGARETTE SMOKE-INDUCED LUNG CELLULAR SENESCENCE
|
RAHMAN, IRFAN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$115,125
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NCI
|
6K24CA139054-06
|
|
Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$46,641
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
7F31HL126459-02
|
|
Novel Endogenous Regulation of Lysosomal Stress Response in Lung Endothelium
|
JUSTICE, MATTHEW
|
NATIONAL JEWISH HEALTH
|
CO
|
$31,786
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
1R56HL126519-01A1
|
|
TLR4-Mediated Mechanisms of Lung Aging
|
LEE, PATTY
|
YALE UNIVERSITY
|
CT
|
$402,618
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
268201400046C-1-0-1
|
|
IGF::OT::IGF SBIR PHASE II TOPIC 62, STRATEGY FOR FINDING CASES OF MODERATE-TO-SEVERE COPD
|
KUMAR, VIKRAM
|
DIMAGI, INC.
|
MA
|
$928,820
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NIEHS
|
1ZIAES043012-17
|
|
Genetics and Environment in Adult Respiratory, Allergic and Cardiac disease
|
LONDON, STEPHANIE
|
NIH
|
|
$385,972
|
Chronic Obstructive Pulmonary Disease
|
2015
|
NHLBI
|
AHL12029001-1-0-1
|
|
Long-term Oxygen Treatment Trial (LOTT)
|
NO PI IDENTIFIED
|
NIH
|
|
$21,945
|